Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy.
adverse events
chemotherapy
dihydropyrimidine dehydrogenase
fluorouracil
pharmacogenetics
precision medicine
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
30 Jun 2022
30 Jun 2022
Historique:
received:
06
06
2022
revised:
24
06
2022
accepted:
27
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
Severe adverse events (toxicity) related to the use of the commonly used chemotherapeutic drug 5-fluorouracil (5-FU) affect one in three patients and are the primary reason cited for premature discontinuation of therapy. Deficiency of the 5-FU catabolic enzyme dihydropyrimidine dehydrogenase (DPD, encoded by
Identifiants
pubmed: 35804978
pii: cancers14133207
doi: 10.3390/cancers14133207
pmc: PMC9264755
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : R01 CA251065
Pays : United States
Références
Cancer Chemother Pharmacol. 2016 Oct;78(4):875-80
pubmed: 27544765
Ann Oncol. 2017 Dec 1;28(12):2915-2922
pubmed: 29045513
Cancer Chemother Pharmacol. 2013 Dec;72(6):1273-82
pubmed: 24101147
Cancer Res. 1987 Apr 15;47(8):2203-6
pubmed: 3829006
Am J Hum Genet. 2019 Jun 6;104(6):1158-1168
pubmed: 31155283
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8699-705
pubmed: 16361556
Br J Clin Pharmacol. 2016 Sep;82(3):706-16
pubmed: 27161955
Biol Chem. 2005 Apr;386(4):319-24
pubmed: 15899693
Clin Colorectal Cancer. 2004 Sep;4(3):181-9
pubmed: 15377401
J Clin Pharm Ther. 2004 Aug;29(4):307-15
pubmed: 15271097
J Pers Med. 2022 Feb 06;12(2):
pubmed: 35207713
Clin Pharmacol Ther. 2014 Feb;95(2):136
pubmed: 24037119
Hum Genet. 1999 Jan;104(1):1-9
pubmed: 10071185
Drug Metab Dispos. 2018 Aug;46(8):1083-1090
pubmed: 29769267
Hum Genet. 2010 Nov;128(5):529-38
pubmed: 20803296
Scand J Immunol. 1976 Jun;Suppl 5:9-15
pubmed: 1052391
Swiss Med Wkly. 2020 Nov 24;150:w20375
pubmed: 33232506
PLoS One. 2017 May 8;12(5):e0175998
pubmed: 28481884
J Clin Invest. 1988 Jan;81(1):47-51
pubmed: 3335642
Pharmacogenomics. 2016 Jun;17(9):979-84
pubmed: 27248859
Clin Pharmacol Ther. 2022 Jul;112(1):62-68
pubmed: 35397172
Br J Cancer. 2020 Dec;123(12):1782-1789
pubmed: 32973300
Pharmacogenomics. 2015;16(11):1277-86
pubmed: 26265346
Eur J Hum Genet. 2020 Apr;28(4):508-517
pubmed: 31745289
Mutat Res. 2003 Jun;543(3):217-34
pubmed: 12787814
Genome Biol. 2019 Mar 1;20(1):48
pubmed: 30823901
Ann Oncol. 2003 Feb;14(2):341-2
pubmed: 12562666
N Engl J Med. 1985 Jul 25;313(4):245-9
pubmed: 2989687
J Clin Oncol. 2016 Jan 20;34(3):227-34
pubmed: 26573078
Mayo Clin Proc. 2014 Jan;89(1):131-136
pubmed: 24388031
Drug Metab Dispos. 1997 May;25(5):270-3
pubmed: 9152608
Clin Cancer Res. 2002 Mar;8(3):768-74
pubmed: 11895907
Biomed Chromatogr. 2013 Jan;27(1):7-16
pubmed: 22454320
Br J Clin Pharmacol. 2021 Aug;87(8):3234-3243
pubmed: 33491253
Br J Cancer. 2017 May 23;116(11):1415-1424
pubmed: 28427087
Clin Cancer Res. 1996 Mar;2(3):507-10
pubmed: 9816197
Genome Biol. 2019 Nov 28;20(1):254
pubmed: 31779641
Clin Pharmacol Ther. 2017 Mar;101(3):382-390
pubmed: 27727460
Cancer Res. 1990 Jan 1;50(1):197-201
pubmed: 2293556
Eur J Cancer. 1997 Nov;33(13):2258-64
pubmed: 9470816
Pharmacogenomics. 2009 Jun;10(6):931-44
pubmed: 19530960
Cancer Res. 2014 May 1;74(9):2545-54
pubmed: 24648345
Cancer Lett. 2007 May 8;249(2):271-82
pubmed: 17064846
Bull Cancer. 2018 Apr;105(4):397-407
pubmed: 29486921
J Natl Compr Canc Netw. 2021 Mar 02;19(3):329-359
pubmed: 33724754
Pharmacogenomics. 2013 Aug;14(11):1255-72
pubmed: 23930673
J Inherit Metab Dis. 1997 Jun;20(2):203-13
pubmed: 9211193
Cancer Res. 1993 Nov 15;53(22):5433-8
pubmed: 8221682
J Clin Invest. 1996 Aug 1;98(3):610-5
pubmed: 8698850
Oncologist. 2021 Dec;26(12):1008-1016
pubmed: 34506675
Clin Cancer Res. 2004 Apr 15;10(8):2652-8
pubmed: 15102667
Cancer. 1991 Aug 1;68(3):499-501
pubmed: 1648430
Clin Pharmacol Ther. 1997 May;61(5):563-73
pubmed: 9164418
Clin Pharmacol Ther. 2014 Feb;95(2):137
pubmed: 24107927
JCO Precis Oncol. 2020 Jun 12;4:
pubmed: 32923881
J Natl Compr Canc Netw. 2021 Apr 1;19(4):439-457
pubmed: 33845462
Br J Clin Pharmacol. 2016 Mar;81(3):553-61
pubmed: 26551538
Cancer. 1996 Feb 1;77(3):441-51
pubmed: 8630950
Br J Cancer. 2020 Sep;123(5):811-818
pubmed: 32595208
Cancer Res. 1992 May 15;52(10):2899-902
pubmed: 1581906
Clin Chem Lab Med. 2022 Jan 21;60(5):e112-e115
pubmed: 35073467
Hum Genet. 1997 Dec;101(3):333-8
pubmed: 9439663
Biochim Biophys Acta. 2016 Apr;1862(4):754-762
pubmed: 26804652
Clin Colorectal Cancer. 2012 Dec;11(4):263-7
pubmed: 22683364
Clin Pharmacol Ther. 2017 Oct;102(4):662-670
pubmed: 28295243
Drug Metab Dispos. 2000 Apr;28(4):467-74
pubmed: 10725316
Ther Drug Monit. 2009 Dec;31(6):688-94
pubmed: 19935361
J Pharmacol Exp Ther. 1998 Nov;287(2):791-9
pubmed: 9808711
Pharmacogenet Genomics. 2016 Mar;26(3):133-7
pubmed: 26658227
Clin Pharmacol Ther. 2013 Jul;94(1):158-66
pubmed: 23588312
JCO Precis Oncol. 2018;2:
pubmed: 32039342
Br J Clin Pharmacol. 1998 Jul;46(1):1-4
pubmed: 9690942
J Natl Cancer Inst. 2014 Nov 07;106(12):
pubmed: 25381393
Ther Drug Monit. 2005 Jun;27(3):362-8
pubmed: 15905808
Cancer Res. 2013 Mar 15;73(6):1958-68
pubmed: 23328581
J Natl Compr Canc Netw. 2020 Apr;18(4):452-478
pubmed: 32259783
Clin Cancer Res. 1999 Aug;5(8):2006-11
pubmed: 10473079
Lancet Oncol. 2015 Dec;16(16):1639-50
pubmed: 26603945
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 25;824(1-2):153-60
pubmed: 16061432
Clin Pharmacol Ther. 2019 Apr;105(4):994-1002
pubmed: 30339275
Lancet Oncol. 2018 Nov;19(11):1459-1467
pubmed: 30348537
J Clin Oncol. 2008 May 1;26(13):2099-105
pubmed: 18445839
J Immunol Methods. 1982;50(2):187-91
pubmed: 6979584
Front Pharmacol. 2020 Jan 28;10:1609
pubmed: 32047438
Cancer Chemother Pharmacol. 2011 Dec;68(6):1611-7
pubmed: 21590448
Clin Pharmacol Ther. 2018 Oct;104(4):709-718
pubmed: 29327356
DNA Cell Biol. 1995 Jan;14(1):1-6
pubmed: 7832988
J Clin Oncol. 1998 Nov;16(11):3537-41
pubmed: 9817272
JCO Oncol Pract. 2020 Dec;16(12):793-798
pubmed: 33197222
Clin Pharmacol Ther. 2018 Feb;103(2):210-216
pubmed: 29152729
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20
pubmed: 23315928
Eur J Cancer. 2019 Jan;107:60-67
pubmed: 30544060
Dose Response. 2018 Oct 01;16(4):1559325818803042
pubmed: 30288154
Lancet Oncol. 2012 Dec;13(12):1225-33
pubmed: 23168362
Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):692-8
pubmed: 18600527
J Inherit Metab Dis. 1996;19(5):645-54
pubmed: 8892022
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Pharmacogenomics. 2014 Sep;15(13):1653-66
pubmed: 25410891
Pharmacogenomics J. 2019 Apr;19(2):115-126
pubmed: 30206299